Login / Signup

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial.

Xenofon BaraliakosLaure GossecEffie PournaraSlawomir JekaAntonio Mera-VarelaSalvatore D'AngeloBarbara SchulzMichael RisslerKriti NagarChiara PerellaLaura C Coates
Published in: Annals of the rheumatic diseases (2020)
NCT02721966.
Keyphrases
  • double blind
  • phase iii
  • placebo controlled
  • clinical trial
  • phase ii
  • study protocol
  • open label
  • ankylosing spondylitis
  • randomized controlled trial
  • rheumatoid arthritis